• Skip to main content
  • Skip to primary sidebar
Pediatric Pulmonology: The Remaining Barriers to Normalcy in Cystic Fibrosis

The Remaining Barriers to Normalcy in Cystic Fibrosis

  • Issues
  • Resources
  • About
  • Contact
  • Search

2020 Quiz Answers

  • 1) Correct! The answer was b)
  • 1) Incorrect. The answer was b) In some, but not all patients, there are reports of decreases in the density of sputum bacteria and apparent improvement in patient health
  • 2) Correct! The answer was a)
  • 2) Incorrect. The answer was a) A proof of concept trial is an example of a study that bridges a Phase I trial with a Phase II trial into a single study
  • 3) Correct! The answer was c)
  • 3) Incorrect. The answer was c) The prevalence of obstructive sleep apnea and associated nocturnal hypoxia in children with CF may be as high as 30%
  • 4) Correct! The answer was d)
  • 4) Incorrect. The answer was d) Transfer RNAs have been utilized in vitro to bypass stop codons in CF airway epithelial cells so that full length CFTR proteins can be produced
  • 5) Correct! The answer was c)
  • 5) Incorrect. The answer was c) Hyperpolarizing magnetic resonance imaging (MRI) holds the promise to develop into a useful mode of analysis of CF lung disease, because it is developing rapidly and can demonstrate both structural and functional features and it does not use ionizing radiation
  • 6) Correct! The answer was b)
  • 6) Incorrect. The answer was b) Current Cystic Fibrosis Foundation/European Cystic Fibrosis Society guidelines call for treatment of NTM-PD (that is sensitive to a macrolide antibiotic) with a macrolide (preferably azithromycin), rifampin and ethambutol
  • 7) Correct! The answer was d)
  • 7) Incorrect. The answer was d) The development of hypoxemia, hypercarbia or pulmonary hypertension are associated with poor outcomes in individuals with ACFLD
  • 8) Correct! The answer was d)
  • 8) Incorrect. The answer was d) The currently available corrector and potentiator agents and their combinations for abnormal CFTR proteins are believed to be effective for 85% of CF individuals
  • 9) Correct! The answer was e)
  • 9) Incorrect. The answer was e) Although the raised volume thoraco-abdominal compression technology replicates adult-type spirometry in infants, its use is limited by the requirement of sedation with chloral hydrate and the procedure is very time- and labor-intensive
  • 10) Correct! The answer was d)
  • 10) Incorrect. The answer was d) An example of healthy developmental stimulation to offset the increase of tasks by parents associated with CF care of infants/toddlers or an increase in the number of diaper changes or increased time with nebulizer treatments is to increase bonding through conversations and increased attention (bonding) with praise for positive behavior
  • 1) Correct! The answer was c)
  • 11) Incorrect. The answer was c) The absorption of amphetamines given to treat ADHD can be increased by the co-administration of proton pump inhibitors to increase the activity of pancreatic enzymes
  • Thanks for completing the quiz!

  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

PP Cover - November 2018

Pediatric Pulmonology

The Remaining Barriers to Normalcy in Cystic Fibrosis I

October 2015 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis II

October 2016 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis III

November 2017 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis IV

November 2018 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis V

November 2019 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis VI

February 2021 · View Articles

The Remaining Barriers to Normalcy in Cystic Fibrosis VII

February 2022 · View Articles

Most Viewed Articles

  • Rapid therapeutic advances in CFTR modulator science

  • Reevaluating approaches to cystic fibrosis pulmonary exacerbations

  • Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors

  • Recent advances in the early treatment of cystic fibrosis: Bridging the gap to highly effective modulator therapy

  • Inflammation in cystic fibrosis: An update

Quiz and Survey

Test your knowledge and help shape future editions of "The Remaining Barriers to Normalcy." Participate in our Quiz and Survey »

This website is made possible by an educational grant from Vertex Pharmaceuticals Incorporated.

Vertex

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2018-2025 John Wiley & Sons, Inc. All Rights Reserved.
The content on this site is intended for health professionals.
Wiley